(Q40722083)

23 September 2017

title

Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells (English)

1 reference

23 September 2017

0 references

1 reference

M J Savontaus

1

1 reference

23 September 2017

B V Sauter

series ordinal

2

1 reference

23 September 2017

T-G Huang

series ordinal

3

1 reference

23 September 2017

S L C Woo

series ordinal

4

1 reference

23 September 2017

publication date

1 July 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

9

1 reference

23 September 2017

issue

14

1 reference

23 September 2017

page(s)

972-979

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301747

23 September 2017

exact match

0 references

cites work

Replication-selective adenoviruses as oncolytic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Progress in antiangiogenic gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Antibody-directed targeting of the vasculature of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

The TATA homology and the mRNA 5' untranslated sequence are not required for expression of essential adenovirus E1A functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Cancer gene therapy: hard lessons and new courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Reduced growth in response to ganciclovir treatment of subcutaneous xenografts expressing HSV-tk in the vascular compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2 (Flk-1) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

7 January 2021

Tumor angiogenesis--new drugs on the block

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

7 January 2021

Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

7 January 2021

Isolation and characterization of insertion mutants in E1A of adenovirus type 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301747

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301747

1 reference

Dimensions Publication ID

23 September 2017

1051062814

0 references

1 reference